479 results on '"Naismith, Robert T"'
Search Results
2. Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.
3. Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension
4. Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study
5. Benefits of early treatment with natalizumab: a real-world study
6. Dimethyl fumarate preserves brainstem and cervical spinal cord integrity in radiologically isolated syndrome.
7. Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients.
8. Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
9. MRI demonstration of gadolinium deposition in bone after monthly triple-dose gadopentetate dimeglumine and correlation with frequency of hypophosphatemia
10. Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial
11. Structural MRI measures are associated with fatigue severity and persistence in a large, real-world cohort of people with multiple sclerosis.
12. Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial
13. Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
14. Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis
15. Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS)
16. Incorporating non-linear alignment and multi-compartmental modeling for improved human optic nerve diffusion imaging
17. Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study
18. Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial.
19. Intensity ratio to improve black hole assessment in multiple sclerosis
20. “Brain age” predicts disability accumulation in multiple sclerosis
21. Safety of the Concurrent Administration of Serotonergic Antidepressants and Ozanimod in Patients With Relapsing Multiple Sclerosis (P7-3.013)
22. Gait asymmetry, and bilateral coordination of gait during a six-minute walk test in persons with multiple sclerosis
23. Diffusion basis spectrum imaging provides insights into MS pathology
24. Author response: Optical coherence tomography for diagnosing optic neuritis: Are we there yet?
25. Optical coherence tomography for diagnosing optic neuritis: Are we there yet?
26. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis
27. Quantitative MRI Identifies Lesional and Non-lesional Abnormalities in MOGAD
28. Use of gadolinium for MRI diagnostic or surveillance studies in patients with MS
29. Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice
30. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome
31. Associations of sNfL with clinico‐radiological measures in a large MS population
32. Further support for rituximab in relapsing multiple sclerosis
33. Plantarflexor Weakness Negatively Impacts Walking in Persons With Multiple Sclerosis More Than Plantarflexor Spasticity
34. OCT as a window to the MS brain: The view becomes slightly clearer
35. Comparaison de l’impact de la titration sur la tolérance gastro-intestinale : diroximel fumarate (DRF) versus diméthyl fumarate (DMF) chez des patients atteints de sclérose en plaques récurrente-rémittente
36. Improved in vivo diffusion tensor imaging of human cervical spinal cord
37. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome.
38. Associations of sNfL with clinico‐radiological measures in a large MS population.
39. No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS
40. Perspectives and experiences with COVID-19 vaccines in people with MS
41. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords
42. Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States
43. Enhancing our understanding of white matter changes in early multiple sclerosis
44. Cortical Lesions in Multiple Sclerosis: Clinical Relevance for a Hidden Disease Burden
45. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis
46. sj-pdf-1-msj-10.1177_13524585211007086 – Supplemental material for Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica
47. sj-pdf-1-tan-10.1177_1756286421993999 – Supplemental material for Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study
48. sj-pdf-2-tan-10.1177_1756286421993999 – Supplemental material for Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study
49. sj-pdf-1-msj-10.1177_13524585211048401 – Supplemental material for Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States
50. sj-pdf-2-msj-10.1177_13524585211048401 – Supplemental material for Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.